OSK Research maintains Buy’ call for KPJ Healthcare OSK Research Sdn Bhd has maintained its Buy’ recommendation on KPJ Healthcare Bhd with a target price of RM4.16. The research firm reiterated the view that KPJ Healthcare is an excellent choice for long term investment and portfolio balancing, offering growth potential in a defensive sector, it said in a research note last Friday On KPJ’s first-quarter result, OSK Research viewed the result as within expectations. KPJ Healthcare posted a higher pretax profit of RM41.55 million for the first-quarter ended March 31, 2011, compared to RM38.04 million in the previous corresponding period. Revenue climbed to RM437.75 million from RM376.05 million previously -Bernarna
|